ACell, Inc. announced that it has entered into an exclusive long-term product supply and distribution agreement with First Horizon, LLC and Weihai Jierui Medical Products Co., Ltd. The terms of the distribution agreement grant exclusive rights to Weihai Jierui for the sale, marketing, and distribution of ACell's MicroMatrix® and Cytal® Wound Matrix devices in China and Hong Kong for 10 years after marketing clearance. Weihai Jierui has also committed to collaborate with ACell on obtaining regulatory approvals necessary prior to commercialization.